(Q40784517)

English

High level synthesis of recombinant soluble urokinase receptor (CD87) by ovarian cancer cells reduces intraperitoneal tumor growth and spread in nude mice

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

High level synthesis of recombinant soluble urokinase receptor (CD87) by ovarian cancer cells reduces intraperitoneal tumor growth and spread in nude mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

1 reference

based on heuristic

inferred from title

author name string

Lutz V

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Reuning U

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Krüger A

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Luther T

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

von Steinburg SP

5

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Graeff H

6

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Schmitt M

7

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Wilhelm OG

8

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Magdolen V

9

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

publication date

1 May 2001

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

382

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

789-798

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.095

21 January 2018

The urokinase-type plasminogen activator system in cancer metastasis: A review

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.095

21 January 2018

Prevention of metastasis by inhibition of the urokinase receptor

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.095

21 January 2018

Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.095

21 January 2018

Proteolytic release of membrane proteins: studies on a membrane-protein-solubilizing activity in CHO cells

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.095

21 January 2018

Urokinase induces proliferation of human ovarian cancer cells: characterization of structural elements required for growth factor function

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.095

21 January 2018

Demonstration of urokinase expression in cancer cells of colon adenocarcinomas by immunohistochemistry and in situ hybridization

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.095

21 January 2018

Urokinase receptor localization in breast cancer and benign lesions assessed by in situ hybridization and immunohistochemistry

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.095

21 January 2018

A bifunctional hybrid molecule of the amino-terminal fragment of urokinase and domain II of bikunin efficiently inhibits tumor cell invasion and metastasis

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.095

21 January 2018

Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.095

21 January 2018

Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87).

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.095

21 January 2018

Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.095

21 January 2018

Adenovirus-mediated delivery of a uPA/uPAR antagonist suppresses angiogenesis-dependent tumor growth and dissemination in mice

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.095

21 January 2018

Expression of the human urokinase‐type plasminogen activator receptor in E. coli and Chinese hamster ovary cells: Purification of the recombinant proteins and generation of polyclonal antibodies in chicken

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.095

21 January 2018

Systematic mutational analysis of the receptor-binding region of the human urokinase-type plasminogen activator.

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.095

21 January 2018

A ligand-free, soluble urokinase receptor is present in the ascitic fluid from patients with ovarian cancer.

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.095

21 January 2018

Prevention of prostate-cancer metastasis in vivo by a novel synthetic inhibitor of urokinase-type plasminogen activator (uPA).

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.095

21 January 2018

Inhibition of NF-kappa B-Rel A expression by antisense oligodeoxynucleotides suppresses synthesis of urokinase-type plasminogen activator (uPA) but not its inhibitor PAI-1.

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.095

21 January 2018

Cloning, expression and mapping of a novel human zinc-finger gene TCF17 homologous to rodent Kid1.

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.095

21 January 2018

Identification and characterization of the murine cell surface receptor for the urokinase-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.095

21 January 2018

Mutational analysis of the genes encoding urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.095

21 January 2018

Regulation of integrin function by the urokinase receptor

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.095

21 January 2018

Antisense inhibition of urokinase reduces spread of human ovarian cancer in mice

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.095

21 January 2018

Recombinant soluble urokinase receptor as a scavenger for urokinase-type plasminogen activator (uPA). Inhibition of proliferation and invasion of human ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.095

21 January 2018

Overexpression of urokinase receptor in breast cancer cells results in increased tumor invasion, growth and metastasis

1 reference

https://api.crossref.org/works/10.1515%2FBC.2001.095

21 January 2018

Identifiers

10.1515/BC.2001.095

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40784517&oldid=1907345700"